Cargando…

Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics

Background: Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is an autosomal recessive disease that prevents the body from utilizing long-chain fatty acids for energy, most needed during stress and fasting. Symptoms can appear from infancy through childhood and adolescence or early adulthoo...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Annibale, Olivia M., Phua, Yu Leng, Van’t Land, Clinton, Karunanidhi, Anuradha, Dorenbaum, Alejandro, Mohsen, Al-Walid, Vockley, Jerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454759/ https://www.ncbi.nlm.nih.gov/pubmed/36078043 http://dx.doi.org/10.3390/cells11172635

Ejemplares similares

A multiomics approach to understanding pathology of Combined D,L-2- Hydroxyglutaric Aciduria and phenylbutyrate as potential treatment
por: Phua, Yu Leng, et al.
Publicado: (2023)

ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts
por: Grings, Mateus, et al.
Publicado: (2019)

ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction
por: Wolfe, Rachel, et al.
Publicado: (2022)

Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency
por: Leipnitz, Guilhian, et al.
Publicado: (2018)

Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders
por: Raimo, Serena, et al.
Publicado: (2021)

Mitochondrial dysfunction associated with TANGO2 deficiency
por: Heiman, Paige, et al.
Publicado: (2022)

Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation
por: Ghaloul-Gonzalez, Lina, et al.
Publicado: (2019)

Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengers
por: Seminotti, Bianca, et al.
Publicado: (2019)

Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiency
por: Prew, Michelle S., et al.
Publicado: (2022)

Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
por: Lee, Mi Young, et al.
Publicado: (2012)

Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction
por: Park, Jeong Rang, et al.
Publicado: (2016)

Clinical course in a patient with myopathic VLCAD deficiency during pregnancy with an affected baby
por: Yamada, Kenji, et al.
Publicado: (2019)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation
por: Verkerk, Arie O., et al.
Publicado: (2021)

ANT2-defective fibroblasts exhibit normal mitochondrial bioenergetics
por: Prabhu, Dolly, et al.
Publicado: (2015)

ACAD10 protein expression and Neurobehavioral assessment of Acad10-deficient mice
por: Bloom, Kaitlyn, et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptor δ Agonist, HPP593, Prevents Renal Necrosis under Chronic Ischemia
por: Fedorova, Larisa V., et al.
Publicado: (2013)

Enantioselective Synthesis of a Novel Thiazoline Core as a Potent Peroxisome Proliferator-Activated Receptor δ Agonist
por: Lee, Su-Jeong, et al.
Publicado: (2018)

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity
por: Hagemeijer, Marne C., et al.
Publicado: (2021)

Transcriptional Regulation of Δ6-Desaturase by Peroxisome Proliferative-Activated Receptor δ Agonist in Human Pancreatic Cancer Cells: Role of MEK/ERK1/2 Pathway
por: Darabi, Maryam, et al.
Publicado: (2013)

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway
por: Bai, Fan, et al.
Publicado: (2019)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
por: Knottnerus, Suzan J. G., et al.
Publicado: (2020)

Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
por: Peters, Jeffrey M., et al.
Publicado: (2015)

Adverse effects of Δ(9)-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
por: Beiersdorf, Johannes, et al.
Publicado: (2020)

Fasting induces prominent proteomic changes in liver in very long chain Acyl-CoA dehydrogenase deficient mice
por: Wang, Wei, et al.
Publicado: (2016)

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(−/−)) mice
por: Tucci, Sara, et al.
Publicado: (2014)

Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts
por: Radzikh, Igor, et al.
Publicado: (2021)

Postmortem diagnosis of very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency in a neonate with sudden cardiac death
por: Singh, Prapti, et al.
Publicado: (2023)

Paradoxes in dynamic stability of mechanical systems: investigating the causes and detecting the nonlinear behaviors
por: Luongo, Angelo, et al.
Publicado: (2016)

Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
por: Cariou, Bertrand, et al.
Publicado: (2013)

Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis
por: Hall, M. G., et al.
Publicado: (2008)

Glutamine energy substrate anaplerosis increases bone density in the Pah(enu2) classical PKU mouse in the absence of phenylalanine restriction
por: Dobrowolski, Steven F., et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism
por: Regnault, Timothy R. H., et al.
Publicado: (2010)

Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
por: Peters, Jeffrey M., et al.
Publicado: (2019)

Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation
por: Watanabe, Kenji, et al.
Publicado: (2018)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

Liposarcoma of the colon presenting as an endoluminal mass
por: D'Annibale, Marco, et al.
Publicado: (2009)

Mixed glycerol and orange peel-based substrate for fed-batch microbial biodiesel production
por: Carota, Eleonora, et al.
Publicado: (2020)

The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
por: Thomas, M. C., et al.
Publicado: (2012)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma
por: Leone, Patrizia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f3gj1nefo62qdbjce245m3halq